Co-Authors
This is a "connection" page, showing publications co-authored by Yeming Wang and Binghuai Lu.
Connection Strength
0.286
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Dec; 62:103125.
Score: 0.229
-
High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):2707-2714.
Score: 0.057